Skip to main content
. 2018 Feb 27;8:3720. doi: 10.1038/s41598-018-22035-z

Figure 3.

Figure 3

Screening of RNAi target genes in BMSB adults by injection of dsRNA. One microgram of dsRNA targeting each of the 13 select genes, ATPase (Putative ATPase N2B, Acc. no: XM_014420983.1); PP1 (Serine/threonine-protein phosphatase PP1-beta catalytic subunit, Acc. no: XM_014431150.1); GPCR (G protein-coupled receptor 161-like, Acc. no. XM_014438952.1); IAP (Baculoviral IAP repeat-containing protein 7-B-like, Acc. no: XM_014435389.1); SNF7 (Charged multivesicular body protein 4b, Acc. no: XM_014427464.1); SRP (Signal recognition particle 54 kDa protein, Acc. no: XM_014419857.1); Actin (Actin-5C, Acc. no: XM_014433214.1); NSF (Alpha-soluble NSF attachment protein, Acc. no: XM_014434606.1); Kanesin (Uncharacterized Kanesin, Acc. no: XM_014426093.1.); Dynamin (Dynamin, Acc. no: XM_014433358.1); 26S (26S protease regulatory subunit 6B, Acc. no: XM_014421516.1); ROP (Protein ROP, Acc. no. XM_014418690.1); HSP70 (Heat shock 70 kDa protein cognate 3, Acc. no: XM_014425902.1) was injected into BMSB adults. The mortality was recorded on the 7th day after injection. dsRNA targeting gene coding for GFP was used as a control.